Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity Common Stock Rollforward (Details)

v3.20.2
Stockholders' Equity Common Stock Rollforward (Details) - shares
 3 Months Ended 9 Months Ended
Mar. 22, 2019
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Dec. 31, 2018
Increase (Decrease) in Common Stock Outstanding [Roll Forward]              
Common shares outstanding at beginning of period (in shares)       272,935,731      
Number of shares of common stock repurchased during period (in shares)   0 (1,500) (105,300) (1,500)    
Common shares outstanding at end of period (in shares)   273,694,411   273,694,411      
Number of nonvested restricted common shares outstanding (in shares)   1,223,020 1,202,252 1,223,020 1,202,252 1,062,901 1,593,701
Common Stock [Member]              
Increase (Decrease) in Common Stock Outstanding [Roll Forward]              
Common shares outstanding at beginning of period (in shares)       272,935,731 248,085,721    
Number of shares of stock issued during period (in shares) 18,000,000     50,729 24,399,107    
Number of shares of restricted common stock issued during period (in shares)       813,251 412,074    
Number of shares of common stock repurchased during period (in shares)       (105,300) (1,500)    
Common shares outstanding at end of period (in shares)   273,694,411 272,895,402 273,694,411 272,895,402